Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 101, Issue 10, 2007, Pages 2139-2144

  Pifarre, Ricard ^a   Falguera, Miquel ^a   Vicente de Vera, Carmina ^a   Nogues, Antonio ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

Chronic obstructive pulmonary disease (COPD); Community acquired pneumonia; Gram negative bacilli; Outcome; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; OXYGEN;

ADULT; AGE; AGED; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROBIAL IDENTIFICATION; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN SATURATION; OXYGEN THERAPY; PH; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK; SEX DIFFERENCE; SPAIN; TACHYPNEA; THORAX RADIOGRAPHY; UNIVERSITY HOSPITAL;

AGE FACTORS; AGED; COMMUNITY-ACQUIRED INFECTIONS; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS; SPAIN; TREATMENT OUTCOME;

EID: 34548227389     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.05.011     Document Type: Article

References (22)

1. Murray C.J.L., and Lopez A.D. Evidence-based health policy-lessons from the global burden of disease study. Science 274 (1996) 740-743
2. Falguera M., Martin M., Ruiz A., et al. Community acquired pneumonia as the initial manifestation of serious underlying disease. Am J Med 118 (2005) 378-383
3. Monso E., Ruiz J., Rosell A., et al. Infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 152 (1995) 1316-1320
4. Carratala J., Ronson B., and Fernadez Sevilla A. Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotics therapy, and outcome. Arch Intern Med 158 (1998) 868-872
5. Janoff E.N., O'Brien J., Thompson P., et al. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis 167 (1993) 49-56
6. Falguera M., Pifarre R., Martin A., et al. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 128 (2005) 3233-3239
7. Celli B.R., MacNee W., et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
8. Lorente M.L., Falguera M., Nogués A., et al. Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study. Thorax 55 (2000) 133-137
9. Falguera M., López A., Nogués A., et al. Evaluation of the PCR method for detection of Streptococcus pneumoniae DNA in pleural fluid samples. Chest 122 (2002) 2212-2216
10. Arancibia F., Bauer T.T., Ewig S., et al. Community-acquired pneumonia due to Gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk-factors and prognosis. Arch Intern Med 162 (2002) 1849-1858
11. Ruiz M., Ewig S., Marcos M.A., et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 160 (1999) 397-405
12. Pena V.S., Miravitlles M., Gabriel R., et al. Geographic variations in prevalence and underdiagnosis of COPD: results of IBERPOC multicentre epidemiological study. Chest 118 (2000) 981-989
13. Ruiz de Ocaña J.M., Gomez M., Celdran J., et al. Neumonía en el paciente con enfermedad pulmonar obstructiva crónica. Niveles de gravedad y clases de riesgo. Arch Bronconeumol 39 (2003) 101-105
14. Fernández-Sabe N., Carratalà J., Rosón B., et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore) 82 (2003) 159-169
15. Restrepo M.I., Mortensen E.M., Pugh J.A., et al. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 28 (2006) 346-351
16. Rello J., Rodríguez A., Torres A., et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 27 (2006) 1210-1216
17. Fine M.J., Auble T.E., Xealdy D.M., et al. A prediction rule to identify low risk patients with community-acquired pneumonia. N Engl J Med 336 (1997) 243-250
18. Sin D.D., Man S.F.P., Thomas J., et al. Arterial carbon dioxide tension on admission as a marker of in-hospital mortality in community-acquired pneumonia. Am J Med 118 (2005) 145-150
19. Niederman M.S., Mandell L.A., Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163 (2001) 1730-1754
20. Normativas para el diagnostico y el tratamiento de la neumonía adquirida en la comunidad. Sociedad Española de Neumologia y Cirugía Toracica (SEPAR). Arch Bronconeumol 41 (2005) 272-289
21. Torres A., Serra-Batlles A., Ferrer A., et al. Severe community-acquired pneumonia. Am Rev Respir Dis 144 (1991) 312-318
22. Lieberman D., Lieberman D., and Gelfer Y. Pneumonic versus nonpneumonic acute exacerbations of COPD. Chest 122 (2002) 1264-1270